SUSQUEHANNA INTERNATIONAL GROUP, LLP - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,054,163
-12.1%
457,210
+10.3%
0.00%
Q2 2023$3,476,539
-73.5%
414,367
-68.6%
0.00%
-100.0%
Q1 2023$13,112,248
+397.1%
1,320,468
+248.5%
0.00%
Q4 2022$2,637,485
+78.2%
378,949
+36.7%
0.00%
Q3 2022$1,480,000
+91.7%
277,194
+43.3%
0.00%
Q2 2022$772,000
-69.3%
193,442
-65.8%
0.00%
Q1 2022$2,517,000
-47.8%
565,914
-53.1%
0.00%
Q4 2021$4,820,000
+87.1%
1,205,376
+311.0%
0.00%
Q3 2021$2,576,000
-38.9%
293,314
-21.1%
0.00%
Q2 2021$4,213,000
-49.2%
371,859
-46.8%
0.00%
-100.0%
Q1 2021$8,301,000
+158.6%
698,827
+49.3%
0.00%
Q4 2020$3,210,000
+213.5%
467,946
+238.8%
0.00%
Q3 2020$1,024,000
+228.2%
138,126
+85.0%
0.00%
Q2 2020$312,000
+173.7%
74,672
+62.7%
0.00%
Q1 2020$114,000
-82.6%
45,893
-59.4%
0.00%
Q4 2019$656,000
+110.3%
112,939
+91.0%
0.00%
Q3 2019$312,000
-85.8%
59,129
-83.9%
0.00%
Q2 2019$2,197,000
+20.7%
366,308
+81.7%
0.00%
Q1 2019$1,820,000
+158.5%
201,566
+137.6%
0.00%
Q4 2018$704,000
-26.1%
84,836
+23.1%
0.00%
Q3 2018$952,000
+46.5%
68,939
-20.4%
0.00%
Q1 2018$650,00086,5840.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Prosight Management, LP 908,488$6,232,0002.88%
Knoll Capital Management, LLC 569,405$3,906,0002.66%
Mesirow Financial Investment Management, Inc. 64,698$443,828,0001.40%
Ghost Tree Capital, LLC 650,000$4,459,0000.99%
Johnson & Johnson Innovation - JJDC, Inc. 594,834$4,081,0000.53%
Perceptive Advisors 6,285,458$43,118,0000.46%
Affinity Asset Advisors, LLC 100,000$686,0000.36%
ACUTA CAPITAL PARTNERS, LLC 192,500$1,321,0000.36%
Avidity Partners Management LP 1,435,000$9,844,0000.32%
APOGEM CAPITAL LLC 55,821$383,0000.26%
View complete list of ALDEYRA THERAPEUTICS INC shareholders